Back to EPRX

UBS Group AG → EPRX

UBS Group AG EPRX Position History

Eupraxia Pharmaceuticals Inc. • Healthcare

Quarters held
16
Latest value
$22K
Q3 2026
Peak value
$5.2M
First seen
Q3 2025

Dollar value over time

Show data table
PeriodPosition value
Q3 2025$215K
Q3 2025$348K
Q3 2025$2K
Q4 2025$276K
Q4 2025$1.4M
Q4 2025$189
Q1 2026$257K
Q1 2026$5.2M
Q1 2026$36K
Q2 2026$235K
Q2 2026$2.4M
Q2 2026$746K
Q2 2026$35K
Q3 2026$323K
Q3 2026$2.1M
Q3 2026$22K

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$22K2.5K——
Q3 2026$2.1M232.2K——
Q3 2026$323K35.5K——
Q2 2026$35K5.3K——
Q2 2026$746K112.9K——
Q2 2026$2.4M365.5K——
Q2 2026$235K35.5K——
Q1 2026$36K4.9K——
Q1 2026$5.2M722.2K——
Q1 2026$257K35.5K——
Q4 2025$18925——
Q4 2025$1.4M183.5K——
Q4 2025$276K36.5K——
Q3 2025$2K356——
Q3 2025$348K58.9K——
Q3 2025$215K36.5K——

Other funds holding EPRX

Other UBS Group AG positions

MSFT

MICROSOFT CORP

$8.1B
AAPL

APPLE INC

$7.8B
NVDA

NVIDIA CORPORATION

$7.8B
AAPL

APPLE INC

$7.7B
NVDA

NVIDIA CORPORATION

$7.7B
MSFT

MICROSOFT CORP

$7.6B
MSFT

MICROSOFT CORP

$7.4B
NVDA

NVIDIA CORPORATION

$7.3B